NCT00197522View on ClinicalTrials.gov

Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Breast Neoplasms
Interventions
BIOLOGICAL

CD34+ derived DCs

Trial Locations (1)

M8V 1C3

Hamilton Health Sciences, Hamilton

All Listed Sponsors
collaborator

Ontario Cancer Research Network

NETWORK

collaborator

Canadian Breast Cancer Research Alliance

OTHER

collaborator

McMaster University

OTHER

lead

Hamilton Health Sciences Corporation

OTHER

NCT00197522 - Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | Biotech Hunter | Biotech Hunter